U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Optic nerve compression

MedGen UID:
78765
Concept ID:
C0271344
Disease or Syndrome
Synonyms: Compression of optic nerve; Compressive optic neuropathy
SNOMED CT: Compression of optic nerve (72983001); Compressive optic neuropathy (72983001); Optic nerve compression (72983001)
 
HPO: HP:0007807

Term Hierarchy

Conditions with this feature

Diaphyseal dysplasia
MedGen UID:
4268
Concept ID:
C0011989
Finding
Camurati-Engelmann disease (CED) is characterized by hyperostosis of the long bones and the skull, proximal muscle weakness, limb pain, a wide-based, waddling gait, and joint contractures. Facial features such as macrocephaly, frontal bossing, enlargement of the mandible, proptosis, and cranial nerve impingement resulting in facial palsy are seen in severely affected individuals later in life.
Osteopetrosis with renal tubular acidosis
MedGen UID:
91042
Concept ID:
C0345407
Disease or Syndrome
Osteopetrosis is a bone disease that makes bone tissue abnormally compact and dense and also prone to breakage (fracture). Researchers have described several major types of osteopetrosis, which are usually distinguished by their pattern of inheritance: autosomal dominant or autosomal recessive. The different types of the disorder can also be distinguished by the severity of their signs and symptoms.\n\nAutosomal dominant osteopetrosis (ADO), which is also called Albers-Schönberg disease, is typically the mildest type of the disorder. Some affected individuals have no symptoms. In affected people with no symptoms, the unusually dense bones may be discovered by accident when an x-ray is done for another reason. \n\nIn individuals with ADO who develop signs and symptoms, the major features of the condition include multiple bone fractures after minor injury, abnormal side-to-side curvature of the spine (scoliosis) or other spinal abnormalities, arthritis in the hips, and a bone infection called osteomyelitis. These problems usually become apparent in late childhood or adolescence.\n\nAutosomal recessive osteopetrosis (ARO) is a more severe form of the disorder that becomes apparent in early infancy. Affected individuals have a high risk of bone fracture resulting from seemingly minor bumps and falls. Their abnormally dense skull bones pinch nerves in the head and face (cranial nerves), often resulting in vision loss, hearing loss, and paralysis of facial muscles. Dense bones can also impair the function of bone marrow, preventing it from producing new blood cells and immune system cells. As a result, people with severe osteopetrosis are at risk of abnormal bleeding, a shortage of red blood cells (anemia), and recurrent infections. In the most severe cases, these bone marrow abnormalities can be life-threatening in infancy or early childhood.\n\nOther features of autosomal recessive osteopetrosis can include slow growth and short stature, dental abnormalities, and an enlarged liver and spleen (hepatosplenomegaly). Depending on the genetic changes involved, people with severe osteopetrosis can also have brain abnormalities, intellectual disability, or recurrent seizures (epilepsy).\n\nA few individuals have been diagnosed with intermediate autosomal osteopetrosis (IAO), a form of the disorder that can have either an autosomal dominant or an autosomal recessive pattern of inheritance. The signs and symptoms of this condition become noticeable in childhood and include an increased risk of bone fracture and anemia. People with this form of the disorder typically do not have life-threatening bone marrow abnormalities. However, some affected individuals have had abnormal calcium deposits (calcifications) in the brain, intellectual disability, and a form of kidney disease called renal tubular acidosis.
Autosomal recessive osteopetrosis 7
MedGen UID:
436770
Concept ID:
C2676766
Disease or Syndrome
A few individuals have been diagnosed with intermediate autosomal osteopetrosis (IAO), a form of the disorder that can have either an autosomal dominant or an autosomal recessive pattern of inheritance. The signs and symptoms of this condition become noticeable in childhood and include an increased risk of bone fracture and anemia. People with this form of the disorder typically do not have life-threatening bone marrow abnormalities. However, some affected individuals have had abnormal calcium deposits (calcifications) in the brain, intellectual disability, and a form of kidney disease called renal tubular acidosis.\n\nOther features of autosomal recessive osteopetrosis can include slow growth and short stature, dental abnormalities, and an enlarged liver and spleen (hepatosplenomegaly). Depending on the genetic changes involved, people with severe osteopetrosis can also have brain abnormalities, intellectual disability, or recurrent seizures (epilepsy).\n\nAutosomal recessive osteopetrosis (ARO) is a more severe form of the disorder that becomes apparent in early infancy. Affected individuals have a high risk of bone fracture resulting from seemingly minor bumps and falls. Their abnormally dense skull bones pinch nerves in the head and face (cranial nerves), often resulting in vision loss, hearing loss, and paralysis of facial muscles. Dense bones can also impair the function of bone marrow, preventing it from producing new blood cells and immune system cells. As a result, people with severe osteopetrosis are at risk of abnormal bleeding, a shortage of red blood cells (anemia), and recurrent infections. In the most severe cases, these bone marrow abnormalities can be life-threatening in infancy or early childhood.\n\nIn individuals with ADO who develop signs and symptoms, the major features of the condition include multiple bone fractures after minor injury, abnormal side-to-side curvature of the spine (scoliosis) or other spinal abnormalities, arthritis in the hips, and a bone infection called osteomyelitis. These problems usually become apparent in late childhood or adolescence.\n\nAutosomal dominant osteopetrosis (ADO), which is also called Albers-Schönberg disease, is typically the mildest type of the disorder. Some affected individuals have no symptoms. In affected people with no symptoms, the unusually dense bones may be discovered by accident when an x-ray is done for another reason. \n\nOsteopetrosis is a bone disease that makes bone tissue abnormally compact and dense and also prone to breakage (fracture). Researchers have described several major types of osteopetrosis, which are usually distinguished by their pattern of inheritance: autosomal dominant or autosomal recessive. The different types of the disorder can also be distinguished by the severity of their signs and symptoms.
Craniotubular dysplasia, Ikegawa type
MedGen UID:
1806238
Concept ID:
C5575335
Disease or Syndrome
Craniotubular dysplasia, Ikegawa type (CTDI) is characterized by childhood-onset short stature in association with macrocephaly, dolichocephaly, or prominent forehead. Radiography shows hyperostosis of the calvaria and skull base, with metadiaphyseal undermodeling of the long tubular bones and mild shortening and diaphyseal broadening of the short tubular bones. Affected individuals experience progressive vision loss in the first decade of life due to optic nerve compression, and deafness may develop in the second decade of life (Guo et al., 2021).

Professional guidelines

PubMed

Westall SJ, Aung ET, Kejem H, Daousi C, Thondam SK
Clin Med (Lond) 2023 Mar;23(2):129-134. doi: 10.7861/clinmed.2023-0020. PMID: 36958836
Poonam NS, Alam MS, Oberoi P, Mukherjee B
Indian J Ophthalmol 2022 Dec;70(12):4419-4426. doi: 10.4103/ijo.IJO_719_22. PMID: 36453357Free PMC Article
Dolman PJ
J Endocrinol Invest 2021 Mar;44(3):421-429. Epub 2020 Jul 29 doi: 10.1007/s40618-020-01361-y. PMID: 32729049

Recent clinical studies

Etiology

Takahashi Y, Vaidya A
Semin Ophthalmol 2023 Jul;38(5):465-474. Epub 2023 Jan 11 doi: 10.1080/08820538.2023.2166354. PMID: 36631972
Nie T, Lamb YN
Drugs 2022 Nov;82(17):1663-1670. Epub 2022 Nov 23 doi: 10.1007/s40265-022-01804-1. PMID: 36418673Free PMC Article
Dolman PJ
J Endocrinol Invest 2021 Mar;44(3):421-429. Epub 2020 Jul 29 doi: 10.1007/s40618-020-01361-y. PMID: 32729049
Thakar A, Lal P, Dhiwakar M, Bahadur S
J Laryngol Otol 2011 Apr;125(4):381-5. doi: 10.1017/S0022215110002689. PMID: 21226984
Kuriyan AE, Phipps RP, Feldon SE
Curr Opin Ophthalmol 2008 Nov;19(6):499-506. doi: 10.1097/ICU.0b013e3283131557. PMID: 18854695Free PMC Article

Diagnosis

Westall SJ, Aung ET, Kejem H, Daousi C, Thondam SK
Clin Med (Lond) 2023 Mar;23(2):129-134. doi: 10.7861/clinmed.2023-0020. PMID: 36958836
Dolman PJ
J Endocrinol Invest 2021 Mar;44(3):421-429. Epub 2020 Jul 29 doi: 10.1007/s40618-020-01361-y. PMID: 32729049
Thakar A, Lal P, Dhiwakar M, Bahadur S
J Laryngol Otol 2011 Apr;125(4):381-5. doi: 10.1017/S0022215110002689. PMID: 21226984
Kirsch E, von Arx G, Hammer B
Orbit 2009;28(4):219-25. PMID: 19839878
Kuriyan AE, Phipps RP, Feldon SE
Curr Opin Ophthalmol 2008 Nov;19(6):499-506. doi: 10.1097/ICU.0b013e3283131557. PMID: 18854695Free PMC Article

Therapy

Nie T, Lamb YN
Drugs 2022 Nov;82(17):1663-1670. Epub 2022 Nov 23 doi: 10.1007/s40265-022-01804-1. PMID: 36418673Free PMC Article
Zurinam O, Safieh C, Redler Y, Orbach A, Lumelsky D, Neeman Z, Briscoe D
Sci Rep 2021 May 26;11(1):11016. doi: 10.1038/s41598-021-90419-9. PMID: 34040074Free PMC Article
Lasunin NV, Cherekaev VA, Serova NK, Gol'bin DA, Kozlov AV, Belov AI, Grigor'eva NN, Krylov KY, Spirin DS
Zh Vopr Neirokhir Im N N Burdenko 2014;78(4):31-41. PMID: 25406807
Kuriyan AE, Phipps RP, Feldon SE
Curr Opin Ophthalmol 2008 Nov;19(6):499-506. doi: 10.1097/ICU.0b013e3283131557. PMID: 18854695Free PMC Article
Chavis PS
Curr Opin Ophthalmol 2002 Dec;13(6):352-6. doi: 10.1097/00055735-200212000-00002. PMID: 12441836

Prognosis

Poonam NS, Alam MS, Oberoi P, Mukherjee B
Indian J Ophthalmol 2022 Dec;70(12):4419-4426. doi: 10.4103/ijo.IJO_719_22. PMID: 36453357Free PMC Article
Danesh-Meyer HV, Yoon JJ, Lawlor M, Savino PJ
Prog Retin Eye Res 2019 Nov;73:100765. Epub 2019 Jun 14 doi: 10.1016/j.preteyeres.2019.06.001. PMID: 31202890
Chavis PS
Curr Opin Ophthalmol 2002 Dec;13(6):352-6. doi: 10.1097/00055735-200212000-00002. PMID: 12441836
Sullivan TJ, Wright JE
Clin Exp Ophthalmol 2000 Feb;28(1):26-31. doi: 10.1046/j.1442-9071.2000.00241.x. PMID: 11345340
Herter T, Bennefeld H, Brandt M
Neurosurg Rev 1988;11(2):143-7. doi: 10.1007/BF01794679. PMID: 3072490

Clinical prediction guides

Nie T, Lamb YN
Drugs 2022 Nov;82(17):1663-1670. Epub 2022 Nov 23 doi: 10.1007/s40265-022-01804-1. PMID: 36418673Free PMC Article
Hwang K, Kim YH, Kim JH, Lee JH, Yang HK, Hwang JM, Kim CY, Han JH
J Neurosurg 2020 Jun 5;134(6):1808-1815. doi: 10.3171/2020.4.JNS192778. PMID: 32502994
Danesh-Meyer HV, Yoon JJ, Lawlor M, Savino PJ
Prog Retin Eye Res 2019 Nov;73:100765. Epub 2019 Jun 14 doi: 10.1016/j.preteyeres.2019.06.001. PMID: 31202890
Lasunin NV, Cherekaev VA, Serova NK, Gol'bin DA, Kozlov AV, Belov AI, Grigor'eva NN, Krylov KY, Spirin DS
Zh Vopr Neirokhir Im N N Burdenko 2014;78(4):31-41. PMID: 25406807
Okada AA, Shore JW, Rubin PA
Int Ophthalmol Clin 1992 Summer;32(3):111-21. PMID: 1639594

Recent systematic reviews

Bouet B, Schlund M, De Massary M, Nicot R
J Stomatol Oral Maxillofac Surg 2023 Dec;124(6S2):101660. Epub 2023 Oct 20 doi: 10.1016/j.jormas.2023.101660. PMID: 37866506
Fan Y, Bao X, Wang R
Clin Interv Aging 2018;13:1981-1985. Epub 2018 Oct 12 doi: 10.2147/CIA.S181109. PMID: 30349217Free PMC Article
Badran KW, Suh JD, Namiri N, Wrobel B, Ference EH
Am J Rhinol Allergy 2018 Nov;32(6):465-472. Epub 2018 Aug 22 doi: 10.1177/1945892418793475. PMID: 30132339

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...